‌

US Patent 11925651 TEAD inhibitors and uses thereof

Patent 11925651 was granted and assigned to Ikena Oncology on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alfredo C. Castro0

Date of Patent

March 12, 2024

0

Patent Application Number

178168590

Date Filed

August 2, 2022

0

Patent Citations

US Patent 7560551 Aurora kinase modulators and method of use

0

US Patent 7582643 Heterocyclic compounds useful in treating diseases and conditions

0

US Patent 7750158 Cannabinoid receptor ligands

0

US Patent 7019142 Process for preparing naphthyridones and intermediates

0

US Patent 7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists

0

US Patent 7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

0

US Patent 7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists

0

US Patent 7501443 Flavaxate derivatives as muscarinic receptor antagonists

0

...

Patent Primary Examiner

Raymond J. Henley, III

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11925651 TEAD inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.